ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $48,000 | -25.0% | 36,284 | 0.0% | 0.00% | – |
| Q4 2021 | $64,000 | -23.8% | 36,284 | -5.8% | 0.00% | – |
| Q3 2021 | $84,000 | -37.8% | 38,536 | 0.0% | 0.00% | – |
| Q2 2021 | $135,000 | -64.5% | 38,536 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $380,000 | -8.0% | 38,536 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $413,000 | +8.7% | 38,112 | +3.2% | 0.00% | 0.0% |
| Q3 2020 | $380,000 | -28.2% | 36,926 | +45.9% | 0.00% | 0.0% |
| Q2 2020 | $529,000 | +72.3% | 25,312 | -19.3% | 0.00% | 0.0% |
| Q1 2020 | $307,000 | +0.3% | 31,375 | +18.2% | 0.00% | 0.0% |
| Q4 2019 | $306,000 | +157.1% | 26,535 | +21.4% | 0.00% | – |
| Q3 2019 | $119,000 | -54.2% | 21,853 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $260,000 | +145.3% | 21,853 | +8.1% | 0.00% | – |
| Q1 2019 | $106,000 | +65.6% | 20,214 | 0.0% | 0.00% | – |
| Q4 2018 | $64,000 | -47.5% | 20,214 | 0.0% | 0.00% | – |
| Q3 2018 | $122,000 | +14.0% | 20,214 | 0.0% | 0.00% | – |
| Q2 2018 | $107,000 | – | 20,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 420,000 | $1,134,000 | 0.67% |
| EcoR1 Capital, LLC | 874,447 | $2,361,000 | 0.60% |
| VHCP Management II, LLC | 280,000 | $756,000 | 0.31% |
| 683 Capital Management, LLC | 350,000 | $945,000 | 0.15% |
| AWM Investment Company, Inc. | 400,000 | $1,080,000 | 0.10% |
| JW Asset Management, LLC | 178,654 | $482,000 | 0.10% |
| TFS CAPITAL LLC | 89,156 | $241,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 154,006 | $416,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 282,630 | $763,000 | 0.04% |
| Numeric Investors LLC | 1,087,967 | $2,938,000 | 0.03% |